# Consolidated Edison Inc: financial statements, quarterly

ED · NYSE · CIK 1047862 · [Utilities](/sectors/utilities.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ed.md) · [Financials](/companies/ed/financials.md) · [Filings](/companies/ed/filings.md) · [Insiders](/companies/ed/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ed/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,773](/filings/0001047862-24-000049.md) | [3,853](/filings/0001047862-24-000064.md) | [3,626 d](/filings/0001047862-26-000031.md) | [4,279](/filings/0001047862-25-000045.md) | [3,300](/filings/0001047862-25-000069.md) | [4,225](/filings/0001047862-25-000138.md) | [3,692 d](/filings/0001047862-26-000031.md) | [4,887](/filings/0001047862-26-000091.md) | [3,629](/filings/0001047862-25-000069.md) | [4,568](/filings/0001047862-25-000138.md) | [3,964 d](/filings/0001047862-26-000031.md) | [5,231](/filings/0001047862-26-000091.md) |
| Operating income | $m | [284](/filings/0001047862-24-000049.md) | [722](/filings/0001047862-24-000064.md) | [451 d](/filings/0001047862-26-000031.md) | [1,011](/filings/0001047862-25-000045.md) | [320](/filings/0001047862-25-000069.md) | [862](/filings/0001047862-25-000138.md) | [477 d](/filings/0001047862-26-000031.md) | [1,125](/filings/0001047862-26-000091.md) | [355](/filings/0001047862-25-000069.md) | [968](/filings/0001047862-25-000138.md) | [487 d](/filings/0001047862-26-000031.md) | [1,177](/filings/0001047862-26-000091.md) |
| Interest expense | $m | [236](/filings/0001047862-24-000049.md) | [259](/filings/0001047862-24-000064.md) | [265 d](/filings/0001047862-26-000031.md) | [289](/filings/0001047862-25-000045.md) | [288](/filings/0001047862-25-000069.md) | [306](/filings/0001047862-25-000138.md) | [304 d](/filings/0001047862-26-000031.md) | [313](/filings/0001047862-26-000091.md) | [300](/filings/0001047862-25-000069.md) | [309](/filings/0001047862-25-000138.md) | [311 d](/filings/0001047862-26-000031.md) | [308](/filings/0001047862-26-000091.md) |
| Income tax | $m | [29.0](/filings/0001047862-24-000049.md) | [144](/filings/0001047862-24-000064.md) | [71.0 d](/filings/0001047862-26-000031.md) | [184](/filings/0001047862-25-000045.md) | [(10.0)](/filings/0001047862-25-000069.md) | [133](/filings/0001047862-25-000138.md) | [11.0 d](/filings/0001047862-26-000031.md) | [242](/filings/0001047862-26-000091.md) | [50.0](/filings/0001047862-25-000069.md) | [202](/filings/0001047862-25-000138.md) | [81.0 d](/filings/0001047862-26-000031.md) | [303](/filings/0001047862-26-000091.md) |
| Net income | $m | [226](/filings/0001047862-24-000049.md) | [526](/filings/0001047862-24-000064.md) | [334 d](/filings/0001047862-26-000031.md) | [720](/filings/0001047862-25-000138.md) | [202](/filings/0001047862-25-000138.md) | [588](/filings/0001047862-25-000138.md) | [310 d](/filings/0001047862-26-000031.md) | [791](/filings/0001047862-26-000091.md) | [246](/filings/0001047862-25-000138.md) | [688](/filings/0001047862-25-000138.md) | [297 d](/filings/0001047862-26-000031.md) | [924](/filings/0001047862-26-000091.md) |
| Diluted EPS | $ per share | [0.65](/filings/0001047862-24-000049.md) | [1.52](/filings/0001047862-24-000064.md) | not reported | [2.08](/filings/0001047862-25-000045.md) | [0.58](/filings/0001047862-25-000069.md) | [1.69](/filings/0001047862-25-000138.md) | not reported | [2.25](/filings/0001047862-26-000091.md) | [0.68](/filings/0001047862-25-000069.md) | [1.90](/filings/0001047862-25-000138.md) | not reported | [2.54](/filings/0001047862-26-000091.md) |
| Basic EPS | $ per share | [0.65](/filings/0001047862-24-000049.md) | [1.53](/filings/0001047862-24-000064.md) | not reported | [2.08](/filings/0001047862-25-000045.md) | [0.58](/filings/0001047862-25-000069.md) | [1.70](/filings/0001047862-25-000138.md) | not reported | [2.26](/filings/0001047862-26-000091.md) | [0.68](/filings/0001047862-25-000069.md) | [1.91](/filings/0001047862-25-000138.md) | not reported | [2.55](/filings/0001047862-26-000091.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [2.0](/filings/0001047862-24-000049.md) | [0.5](/filings/0001047862-24-000064.md) | [1.2](/filings/0001047862-25-000011.md) | [0.2](/filings/0001047862-25-000045.md) | [1.5](/filings/0001047862-25-000069.md) | [0.1](/filings/0001047862-25-000138.md) | [1.3](/filings/0001047862-26-000031.md) | [0.4](/filings/0001047862-25-000045.md) | [1.5](/filings/0001047862-25-000069.md) | [0.2](/filings/0001047862-25-000138.md) | [1.6](/filings/0001047862-26-000091.md) | [0.1](/filings/0001047862-26-000091.md) |
| Current assets | $bn | [6.2](/filings/0001047862-23-000140.md) | [5.9](/filings/0001047862-23-000161.md) | [6.5](/filings/0001047862-25-000011.md) | [6.2](/filings/0001047862-24-000030.md) | [6.5](/filings/0001047862-24-000049.md) | [6.1](/filings/0001047862-24-000064.md) | [6.7](/filings/0001047862-26-000031.md) | [6.1](/filings/0001047862-25-000045.md) | [6.1](/filings/0001047862-25-000069.md) | [5.5](/filings/0001047862-25-000138.md) | [6.8](/filings/0001047862-26-000091.md) | [6.3](/filings/0001047862-26-000091.md) |
| Total assets | $bn | [63.8](/filings/0001047862-23-000140.md) | [64.4](/filings/0001047862-23-000161.md) | [66.3](/filings/0001047862-26-000031.md) | [66.7](/filings/0001047862-25-000045.md) | [67.9](/filings/0001047862-25-000069.md) | [68.6](/filings/0001047862-25-000138.md) | [70.6](/filings/0001047862-26-000031.md) | [70.7](/filings/0001047862-26-000091.md) | [71.5](/filings/0001047862-25-000069.md) | [71.8](/filings/0001047862-25-000138.md) | [74.6](/filings/0001047862-26-000091.md) | [74.7](/filings/0001047862-26-000091.md) |
| Current liabilities | $bn | [6.1](/filings/0001047862-23-000140.md) | [6.1](/filings/0001047862-23-000161.md) | [6.5](/filings/0001047862-25-000011.md) | [6.2](/filings/0001047862-24-000030.md) | [6.2](/filings/0001047862-24-000049.md) | [6.0](/filings/0001047862-24-000064.md) | [6.4](/filings/0001047862-26-000031.md) | [4.8](/filings/0001047862-25-000045.md) | [5.5](/filings/0001047862-25-000069.md) | [5.1](/filings/0001047862-25-000138.md) | [6.6](/filings/0001047862-26-000091.md) | [5.3](/filings/0001047862-26-000091.md) |
| Long-term debt | $bn | [20.6](/filings/0001047862-23-000140.md) | [20.7](/filings/0001047862-23-000161.md) | [22.0](/filings/0001047862-25-000011.md) | [21.9](/filings/0001047862-24-000030.md) | [23.3](/filings/0001047862-24-000049.md) | [23.4](/filings/0001047862-24-000064.md) | [24.7](/filings/0001047862-26-000031.md) | not reported | not reported | not reported | [25.6](/filings/0001047862-26-000031.md) | not reported |
| Current portion of debt | $bn | not reported | not reported | [0.3](/filings/0001047862-25-000011.md) | not reported | not reported | not reported | [0.0](/filings/0001047862-26-000031.md) | not reported | not reported | not reported | [0.3](/filings/0001047862-26-000031.md) | not reported |
| Short-term borrowings | $bn | [2.0](/filings/0001047862-23-000140.md) | [1.9](/filings/0001047862-23-000161.md) | [2.3](/filings/0001047862-25-000011.md) | [2.3](/filings/0001047862-24-000030.md) | [2.5](/filings/0001047862-24-000049.md) | [2.1](/filings/0001047862-24-000064.md) | [2.2](/filings/0001047862-25-000138.md) | [0.4](/filings/0001047862-25-000045.md) | [1.2](/filings/0001047862-25-000069.md) | [0.6](/filings/0001047862-25-000138.md) | not reported | [0.9](/filings/0001047862-26-000091.md) |
| Shareholders' equity | $bn | [20.8](/filings/0001047862-23-000140.md) | [21.1](/filings/0001047862-23-000161.md) | [21.2](/filings/0001047862-25-000138.md) | [21.6](/filings/0001047862-25-000138.md) | [21.6](/filings/0001047862-25-000138.md) | [21.9](/filings/0001047862-25-000138.md) | [22.0](/filings/0001047862-26-000031.md) | [23.8](/filings/0001047862-25-000138.md) | [23.8](/filings/0001047862-25-000138.md) | [24.2](/filings/0001047862-25-000138.md) | [24.2](/filings/0001047862-26-000091.md) | [25.6](/filings/0001047862-26-000091.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:CommercialPaper
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [1,072 d](/filings/0001047862-24-000049.md) | [17.0 d](/filings/0001047862-24-000064.md) | [975 d](/filings/0001047862-26-000031.md) | [573](/filings/0001047862-25-000045.md) | [1,339 d](/filings/0001047862-25-000069.md) | [392 d](/filings/0001047862-25-000138.md) | [1,310 d](/filings/0001047862-26-000031.md) | [837](/filings/0001047862-26-000091.md) | [1,979 d](/filings/0001047862-25-000069.md) | [504 d](/filings/0001047862-25-000138.md) | [1,480 d](/filings/0001047862-26-000031.md) | [174](/filings/0001047862-26-000091.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [278 d](/filings/0001047862-24-000049.md) | [267 d](/filings/0001047862-24-000064.md) | [267 d](/filings/0001047862-26-000031.md) | [274](/filings/0001047862-25-000045.md) | [275 d](/filings/0001047862-25-000069.md) | [275 d](/filings/0001047862-25-000138.md) | [276 d](/filings/0001047862-26-000031.md) | [282](/filings/0001047862-26-000091.md) | [294 d](/filings/0001047862-25-000069.md) | [295 d](/filings/0001047862-25-000138.md) | [295 d](/filings/0001047862-26-000031.md) | [308](/filings/0001047862-26-000091.md) |
| Share repurchases | $m | [0.0 d](/filings/0001047862-24-000049.md) | [0.0 d](/filings/0001047862-24-000064.md) | [0.0 d](/filings/0001047862-26-000031.md) | [0.0](/filings/0001047862-24-000030.md) | [0.0 d](/filings/0001047862-24-000049.md) | [0.0 d](/filings/0001047862-24-000064.md) | [0.0 d](/filings/0001047862-26-000031.md) | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q2 FY2022 (2022-06-30) | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [356](/filings/0001047862-23-000140.md) | [356](/filings/0001047862-23-000161.md) | [354](/filings/0001047862-24-000030.md) | [347](/filings/0001047862-24-000049.md) | [347](/filings/0001047862-24-000064.md) | [347](/filings/0001047862-25-000045.md) | [347](/filings/0001047862-25-000069.md) | [348](/filings/0001047862-25-000138.md) | [351](/filings/0001047862-26-000091.md) | [362](/filings/0001047862-25-000069.md) | [362](/filings/0001047862-25-000138.md) | [364](/filings/0001047862-26-000091.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 368,529,705 at 2026-04-30, from the cover of the [10-Q filed 2026-05-07](/filings/0001047862-26-000091.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:31 ET. No prices; not investment advice.